Commodore-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
31
Total Value
1357083846
Accession Number
0001831942-25-000005
Form Type
13F-HR
Manager Name
Commodore-Capital-Lp
Data Enrichment
94% identified
29 identified2 unidentified

Holdings

31 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
Merus N.V.
Shares:4.5M
Value:$188.3M
Nuvalent, Inc.
Shares:1.9M
Value:$131.6M
Enliven Therapeutics, Inc.
Shares:4.7M
Value:$92.0M
SOLENO THERAPEUTICS INC
Shares:1.1M
Value:$82.2M
Xenon Pharmaceuticals Inc.
Shares:2.3M
Value:$78.0M
Alkermes plc.
Shares:1.9M
Value:$64.4M
AGIOS PHARMACEUTICALS, INC.
Shares:2.2M
Value:$64.0M
Vaxcyte, Inc.
Shares:1.6M
Value:$62.3M
Vera Therapeutics, Inc.
Shares:2.6M
Value:$61.5M
Celldex Therapeutics, Inc.
Shares:3.2M
Value:$58.1M
Scholar Rock Holding Corp
Shares:1.7M
Value:$56.1M
Cogent Biosciences, Inc.
Shares:8.9M
Value:$53.3M
Viridian Therapeutics, Inc.\DE
Shares:3.6M
Value:$48.5M
Nurix Therapeutics, Inc.
Shares:4.0M
Value:$47.3M
Centessa Pharmaceuticals plc
Shares:2.4M
Value:$34.0M
Spyre Therapeutics, Inc.
Shares:2.0M
Value:$32.1M
Pharvaris N.V.
Shares:1.9M
Value:$30.0M
Mind Medicine (MindMed) Inc.
Shares:4.5M
Value:$26.5M
Solid Biosciences Inc.
Shares:5.8M
Value:$21.6M
10919W405
Shares:500.0K
Value:$18.0M